These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5787318)

  • 21. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
    Braunsteiner H; Herbst M; Sandhofer F; Sailer S
    Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypercholesterolemia and control with therapy].
    von Eckardstein A
    Praxis (Bern 1994); 2007 Apr; 96(15):583. PubMed ID: 17506387
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

  • 24. Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man.
    Horlick L; Kudchodkar BJ; Sodhi HS
    Circulation; 1971 Feb; 43(2):299-309. PubMed ID: 5540713
    [No Abstract]   [Full Text] [Related]  

  • 25. Long term human studies on the lipid effects of oral calcium.
    Bierenbaum ML; Fleischman AI; Raichelson RI
    Lipids; 1972 Mar; 7(3):202-6. PubMed ID: 5021330
    [No Abstract]   [Full Text] [Related]  

  • 26. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S; Esilä R; Tuovinen E
    Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U; Johannes KJ
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a phenolic ether, Su-13437, on serum cholesterol, triglyceride, and transaminase levels of human subjects.
    Duncan CH; Best MM
    Circulation; 1970 Nov; 42(5):859-65. PubMed ID: 5477258
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate.
    Samuel P; Holtzman CM; Meilman E; Sekowski I
    Circulation; 1970 Jan; 41(1):109-14. PubMed ID: 5420622
    [No Abstract]   [Full Text] [Related]  

  • 30. [CHOLESTEROL AND BLOOD LIPID BEHAVIOR IN ARTERIOSCLEROSIS UNDER THE EFFECTS OF PROTECTED ANDROSTERONE (ATROMID)].
    MARIN R; GARCIAFERNANDEZ JL; GARCIAOTERO V; RODRIGUEZPUCHOL J; PESCADOR L
    Rev Esp Cardiol; 1964 Jul; 17():563-73. PubMed ID: 14232044
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.
    Carson P; McDonald L; Pickard S; Pilkington T; Davies B; Love F
    Br Heart J; 1966 May; 28(3):400-3. PubMed ID: 5936972
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperlipidemias: occurrence, significance, therapy].
    Knüchel F
    Med Welt; 1967 Aug; 32():1848-60. PubMed ID: 5589916
    [No Abstract]   [Full Text] [Related]  

  • 34. THE EFFECTS OF ATROMID ON SERUM CHOLESTEROL, SERUM TRIGLYCERIDES, AND RADIOACTIVE FAT TOLERANCE IN PATIENTS WITH HYPERLIPIDEMIA. A PRELIMINARY REPORT.
    BERKOWITZ D
    J Atheroscler Res; 1963; 3():538-41. PubMed ID: 14100895
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug therapy of dyslipidemias].
    Fonda M; Cattin L; Guarnieri G
    Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract]   [Full Text] [Related]  

  • 36. Current pharmacologic treatment of elevated serum cholesterol.
    Tikkanen MJ; Nikkilä EA
    Circulation; 1987 Sep; 76(3):529-33. PubMed ID: 3476221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of Regelan (Atromid-S) on serum lipids and platelet aggregation in occlusive arterial disease].
    Fischer M; Irsigler K
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):248-51. PubMed ID: 4880993
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
    Giuliani A; Trezzini C; Urbinati G; Conti R
    Clin Ter; 1979 Mar; 88(5):481-9. PubMed ID: 466970
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preliminary research on the effects of administration of CoA on plasmatic lipids in humans].
    Arrigo F; Vitale D; Consolo F
    Clin Ter; 1974 Dec; 71(5):459-68. PubMed ID: 4452226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.